目次

Table of Contents

1. Executive Summary

2. mRNA Cancer Vaccines And Therapeutics Market Characteristics

3. mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies

4. mRNA Cancer Vaccines And Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global mRNA Cancer Vaccines And Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global mRNA Cancer Vaccines And Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global mRNA Cancer Vaccines And Therapeutics Market Growth Rate Analysis
5.4. Global mRNA Cancer Vaccines And Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global mRNA Cancer Vaccines And Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global mRNA Cancer Vaccines And Therapeutics Total Addressable Market (TAM)

6. mRNA Cancer Vaccines And Therapeutics Market Segmentation
6.1. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
6.2. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease
Cancer
Other Applications
6.3. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgical Centers
Research Institutes
Other End Users
6.4. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Adenocarcinomas
Colon Adenocarcinomas
Prostate Adenocarcinomas
6.5. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mucinous Ovarian Cancer
Mucinous Breast Cancer
Mucinous Colorectal Cancer
6.6. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pancreatic Adenosquamous Carcinoma
Cervical Adenosquamous Carcinoma
Esophageal Adenosquamous Carcinoma

7. mRNA Cancer Vaccines And Therapeutics Market Regional And Country Analysis
7.1. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market
8.1. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China mRNA Cancer Vaccines And Therapeutics Market
9.1. China mRNA Cancer Vaccines And Therapeutics Market Overview
9.2. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India mRNA Cancer Vaccines And Therapeutics Market
10.1. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan mRNA Cancer Vaccines And Therapeutics Market
11.1. Japan mRNA Cancer Vaccines And Therapeutics Market Overview
11.2. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia mRNA Cancer Vaccines And Therapeutics Market
12.1. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia mRNA Cancer Vaccines And Therapeutics Market
13.1. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea mRNA Cancer Vaccines And Therapeutics Market
14.1. South Korea mRNA Cancer Vaccines And Therapeutics Market Overview
14.2. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe mRNA Cancer Vaccines And Therapeutics Market
15.1. Western Europe mRNA Cancer Vaccines And Therapeutics Market Overview
15.2. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK mRNA Cancer Vaccines And Therapeutics Market
16.1. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany mRNA Cancer Vaccines And Therapeutics Market
17.1. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France mRNA Cancer Vaccines And Therapeutics Market
18.1. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy mRNA Cancer Vaccines And Therapeutics Market
19.1. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain mRNA Cancer Vaccines And Therapeutics Market
20.1. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market
21.1. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market Overview
21.2. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia mRNA Cancer Vaccines And Therapeutics Market
22.1. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America mRNA Cancer Vaccines And Therapeutics Market
23.1. North America mRNA Cancer Vaccines And Therapeutics Market Overview
23.2. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA mRNA Cancer Vaccines And Therapeutics Market
24.1. USA mRNA Cancer Vaccines And Therapeutics Market Overview
24.2. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada mRNA Cancer Vaccines And Therapeutics Market
25.1. Canada mRNA Cancer Vaccines And Therapeutics Market Overview
25.2. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America mRNA Cancer Vaccines And Therapeutics Market
26.1. South America mRNA Cancer Vaccines And Therapeutics Market Overview
26.2. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil mRNA Cancer Vaccines And Therapeutics Market
27.1. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East mRNA Cancer Vaccines And Therapeutics Market
28.1. Middle East mRNA Cancer Vaccines And Therapeutics Market Overview
28.2. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa mRNA Cancer Vaccines And Therapeutics Market
29.1. Africa mRNA Cancer Vaccines And Therapeutics Market Overview
29.2. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Company Profiles
30.1. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape
30.2. mRNA Cancer Vaccines And Therapeutics Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis SA Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi AG Overview, Products and Services, Strategy and Financial Analysis

31. mRNA Cancer Vaccines And Therapeutics Market Other Major And Innovative Companies
31.1. AstraZeneca Plc
31.2. GlaxoSmithKline Plc
31.3. Hoffmann-La Roche AG
31.4. Eli Lilly and Company
31.5. Moderna Therapeutics Inc.
31.6. BioNTech SE
31.7. Regeneron Pharmaceuticals Inc.
31.8. Catalent Inc.
31.9. Sarepta Therapeutics Inc.
31.10. Arcturus Therapeutics Holdings Inc.
31.11. Genentech Inc.
31.12. Immatics Biotechnologies GmbH
31.13. CureVac N.V.
31.14. Anima Biotech
31.15. Argos Therapeutics Inc.

32. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market

34. Recent Developments In The mRNA Cancer Vaccines And Therapeutics Market

35. mRNA Cancer Vaccines And Therapeutics Market High Potential Countries, Segments and Strategies
35.1 mRNA Cancer Vaccines And Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 mRNA Cancer Vaccines And Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 mRNA Cancer Vaccines And Therapeutics Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2019-2024, $ Billion
Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
Table 3: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 4: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 5: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 6: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 7: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 8: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 9: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 10: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 11: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 12: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 13: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 14: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 15: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 16: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 17: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 18: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 19: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 20: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 21: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 22: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 23: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 24: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 25: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 26: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 27: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 28: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 29: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 30: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 31: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 32: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 33: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 34: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 35: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 36: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 37: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 38: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 39: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 40: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 41: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 42: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 43: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 44: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 45: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 46: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 47: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 48: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 49: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 50: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 51: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 52: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 53: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 54: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 55: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 56: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 57: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 58: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 59: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 60: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 61: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 62: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 63: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 64: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 65: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 66: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 67: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 68: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 69: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 70: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 71: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 72: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 73: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 74: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 75: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 76: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 77: Pfizer Inc. Financial Performance
Table 78: Merck & Co Inc. Financial Performance
Table 79: Bayer AG Financial Performance
Table 80: Novartis SA Financial Performance
Table 81: Sanofi AG Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
Figure 3: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 4: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 5: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 6: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 7: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 8: Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 9: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 10: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 11: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 12: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 13: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 14: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 15: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 16: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 17: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 18: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 19: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 20: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 21: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 22: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 23: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 24: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 25: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 26: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 27: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 28: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 29: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 30: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 31: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 32: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 33: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 34: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 35: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 36: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 37: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 38: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 39: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 40: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 41: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 42: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 43: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 44: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 45: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 46: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 47: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 48: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 49: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 50: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 51: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 52: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 53: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 54: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 55: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 56: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 57: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 58: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 59: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 60: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 61: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 62: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 63: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 64: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 65: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 66: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 67: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 68: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 69: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 70: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 71: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 72: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 73: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 74: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 75: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 76: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 77: Pfizer Inc. Financial Performance
Figure 78: Merck & Co Inc. Financial Performance
Figure 79: Bayer AG Financial Performance
Figure 80: Novartis SA Financial Performance
Figure 81: Sanofi AG Financial Performance